These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8745836)

  • 1. [Prophylaxis of late hemorrhagic disease in newborn infants with vitamin K1 at birth].
    Besson-Leaud M; Aucher C; Boniface C
    Arch Pediatr; 1996 Jan; 3(1):89-90; author reply 90. PubMed ID: 8745836
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of haemorrhagic disease of the newborn. Routine vitamin K1 administration is justified.
    Prescrire Int; 1998 Aug; 7(36):125-7. PubMed ID: 10342952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly oral vitamin K prophylaxis in Denmark.
    Hansen KN; Minousis M; Ebbesen F
    Acta Paediatr; 2003 Jul; 92(7):802-5. PubMed ID: 12892158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does intramuscular vitamin K1 act as an unintended depot preparation?
    Loughnan PM; McDougall PN
    J Paediatr Child Health; 1996 Jun; 32(3):251-4. PubMed ID: 8827545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K deficiency bleeding after missed prophylaxis: rapid synergistic effect of vitamin K therapy on hemostasis.
    Clarke P; Shearer MJ
    South Med J; 2007 Jun; 100(6):612-3. PubMed ID: 17593579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral vitamin K prophylaxis in newborn with a diluted konakion solution].
    WESPI HJ
    Ther Ggw; 1959 Jan; (1):5-7. PubMed ID: 13647457
    [No Abstract]   [Full Text] [Related]  

  • 7. Late onset haemorrhagic disease in premature infants who received intravenous vitamin K1.
    Loughnan PM; McDougall PN; Balvin H; Doyle LW; Smith AL
    J Paediatr Child Health; 1996 Jun; 32(3):268-9. PubMed ID: 8827551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K deficiency bleeding: a case study.
    Woods CW; Woods AG; Cederholm CK
    Adv Neonatal Care; 2013 Dec; 13(6):402-7. PubMed ID: 24300958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.
    Pereira SP; Shearer MJ; Williams R; Mieli-Vergani G
    Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F113-8. PubMed ID: 12598499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can prenatal vitamin K1 (phylloquinone) supplementation replace prophylaxis at birth?
    Anai T; Hirota Y; Yoshimatsu J; Oga M; Miyakawa I
    Obstet Gynecol; 1993 Feb; 81(2):251-4. PubMed ID: 8423960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K and hemorrhagic disease of newborns.
    Waseem M
    South Med J; 2006 Nov; 99(11):1199. PubMed ID: 17195407
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of vitamin K metabolites in term and preterm infants: relationship to vitamin K status and prophylaxis.
    Harrington DJ; Clarke P; Card DJ; Mitchell SJ; Shearer MJ
    Pediatr Res; 2010 Dec; 68(6):508-12. PubMed ID: 20814348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of vitamin K deficiency bleeding with three oral mixed micellar phylloquinone doses: results of a 6-year (2005-2011) surveillance in Switzerland.
    Laubscher B; Bänziger O; Schubiger G;
    Eur J Pediatr; 2013 Mar; 172(3):357-60. PubMed ID: 23192459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educating Parents on Vitamin K Prophylaxis for Newborns.
    Holley SL; Green K; Mills M; Detterman C; Rappold MF; Thayer S
    Nurs Womens Health; 2020 Aug; 24(4):283-293. PubMed ID: 32778394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ireland lacks consensus on neonatal vitamin K prophylaxis.
    Philip RK; Gul R; Dunworth M; Keane N
    BMJ; 2001 Nov; 323(7320):1068. PubMed ID: 11691771
    [No Abstract]   [Full Text] [Related]  

  • 16. [Implication of the routine administration of phytonadione in hemorrhagic disease of the newborn].
    Kaneoka T; Ogawa E
    Sanfujinka No Jissai; 1965 Nov; 14(11):946-58. PubMed ID: 5899489
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivering neonatal vitamin K prophylaxis: the continuing need for surveillance and vigilance.
    Shearer MJ
    Arch Dis Child; 2020 May; 105(5):417-418. PubMed ID: 32060031
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination half-life of vitamin K1 in neonates is longer than is generally assumed: implications for the prophylaxis of haemorrhaghic disease of the newborn.
    Stoeckel K; Joubert PH; Grüter J
    Eur J Clin Pharmacol; 1996; 49(5):421-3. PubMed ID: 8866641
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic vitamin K and haemorrhagic disease of the newborn.
    Bridgman GC
    Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134071
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracerebral hemorrhage due to hemorrhagic disease of the newborn and failure to administer vitamin K at birth.
    Hubbard D; Tobias JD
    South Med J; 2006 Nov; 99(11):1216-20. PubMed ID: 17195415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.